Jun 09, 2021 / 08:40PM GMT
Terence C. Flynn - Goldman Sachs Group, Inc., Research Division - MD
Great. Good afternoon, everybody. I'm Terence Flynn, the U.S. biopharma analyst at Goldman Sachs, and we're very pleased to be hosting Amgen today at our virtual conference. Joining us today from the company, we have Peter Griffith, the company's CFO; Dave Reese, Head of Research and Development; and Arvind Sood, Head of Investor Relations. Thanks so much for joining us today. Really appreciate the time.
Peter, I'm going to turn it over to you for some opening remarks before we go into Q&A.
Peter H. Griffith - Amgen Inc. - Executive VP & CFO
Great. Well, thank you, everybody, for joining us. Thank you, Terence. Thank you, Goldman Sachs, for the invitation. We look forward hopefully to seeing everybody at Terranea next year. I won't share with you the weather out here today. You wouldn't want to know it's 70 degrees. But rest assured, you're saving some money on your sunblock and your sunscreen by not being here.
Well, we've been busy as we near the first half of the
Amgen Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers